Geode Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $388M | Buy |
|
|||||
|
2023
Q2 | $337M | Buy |
|
|||||
|
2023
Q1 | $346M | Buy |
|
|||||
|
2022
Q4 | $349M | Buy |
|
|||||
|
2022
Q3 | $187M | Buy |
|
|||||
|
2022
Q2 | $239M | Sell |
|
|||||
|
2022
Q1 | $317M | Buy |
|
|||||
|
2021
Q4 | $313M | Buy |
|
|||||
|
2021
Q3 | $308M | Buy |
|
|||||
|
2021
Q2 | $263M | Buy |
|
|||||
|
2021
Q1 | $249M | Buy |
|
|||||
|
2020
Q4 | $191M | Buy |
|
|||||
|
2020
Q3 | $182M | Buy |
|
|||||
|
2020
Q2 | $124M | Buy |
|
|||||
|
2020
Q1 | $65.6M | Buy |
|
|||||
|
2019
Q4 | $76.8M | Buy |
|
|||||
|
2019
Q3 | $56M | Sell |
|
|||||
|
2019
Q2 | $49.9M | Sell |
|
|||||
|
2019
Q1 | $59.3M | Buy |
|
|||||
|
2018
Q4 | $37.8M | Buy |
|
|||||
|
2018
Q3 | $34.8M | Sell |
|
|||||
|
2018
Q2 | $29.5M | Buy |
|
|||||
|
2018
Q1 | $23.1M | Buy |
|
|||||
|
2017
Q4 | $22.1M | Buy |
|
|||||
|
2017
Q3 | $18.9M | Buy |
|
|||||
|
2017
Q2 | $16.9M | Buy |
|
|||||
|
2017
Q1 | $20.4M | Buy |
|
|||||
|
2016
Q4 | $22.2M | Buy |
|
|||||
|
2016
Q3 | $21.7M | Buy |
|
|||||
|
2016
Q2 | $18.2M | Buy |
|
|||||
|
2016
Q1 | $13.8K | Buy |
|
|||||
|
2015
Q4 | $17.4M | Buy |
|
|||||
|
2015
Q3 | $15.2M | Buy |
|
|||||
|
2015
Q2 | $26.6M | Buy |
|
|||||
|
2015
Q1 | $12M | Buy |
|
|||||
|
2014
Q4 | $5.21M | Buy |
|
|||||
|
2014
Q3 | $4.43M | Buy |
|
|||||
|
2014
Q2 | $5.38M | Buy |
|
|||||
|
2014
Q1 | $4.87M | Buy |
|
|||||
|
2013
Q4 | $1.77M | Buy |
|
|||||
|
2013
Q3 | $693K | Buy |
|
|||||
|
2013
Q2 | $411K | Buy |
|